MXPA04002709A - Derivados articonvulsivos utiles para el tratamiento del sindrome de extremidades inquietas y trastorno periodico del movimiento de extremidades. - Google Patents

Derivados articonvulsivos utiles para el tratamiento del sindrome de extremidades inquietas y trastorno periodico del movimiento de extremidades.

Info

Publication number
MXPA04002709A
MXPA04002709A MXPA04002709A MXPA04002709A MXPA04002709A MX PA04002709 A MXPA04002709 A MX PA04002709A MX PA04002709 A MXPA04002709 A MX PA04002709A MX PA04002709 A MXPA04002709 A MX PA04002709A MX PA04002709 A MXPA04002709 A MX PA04002709A
Authority
MX
Mexico
Prior art keywords
restless
syndrome
formula
topiramate
alkyl
Prior art date
Application number
MXPA04002709A
Other languages
English (en)
Spanish (es)
Inventor
S Abuzzahab Faruk
Original Assignee
Johnson & Johnson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson filed Critical Johnson & Johnson
Publication of MXPA04002709A publication Critical patent/MXPA04002709A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
MXPA04002709A 2001-09-24 2002-09-23 Derivados articonvulsivos utiles para el tratamiento del sindrome de extremidades inquietas y trastorno periodico del movimiento de extremidades. MXPA04002709A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32444001P 2001-09-24 2001-09-24
PCT/US2002/030194 WO2003026676A1 (en) 2001-09-24 2002-09-23 Anticonvulsant derivatives useful for the treatment of restless limb syndrome and periodic limb movement disorder
US10/252,814 US20030092759A1 (en) 2001-09-24 2002-09-23 Anticonvulsant derivatives useful for the treatment of restless limb syndrome and periodic limb movement disorder

Publications (1)

Publication Number Publication Date
MXPA04002709A true MXPA04002709A (es) 2005-06-06

Family

ID=23263595

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04002709A MXPA04002709A (es) 2001-09-24 2002-09-23 Derivados articonvulsivos utiles para el tratamiento del sindrome de extremidades inquietas y trastorno periodico del movimiento de extremidades.

Country Status (8)

Country Link
US (1) US20030092759A1 (https=)
EP (1) EP1429787A1 (https=)
JP (1) JP2005512965A (https=)
AU (1) AU2002336765B2 (https=)
CA (1) CA2461539A1 (https=)
MX (1) MXPA04002709A (https=)
NZ (1) NZ531871A (https=)
WO (1) WO2003026676A1 (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6375957B1 (en) 1997-12-22 2002-04-23 Euro-Celtique, S.A. Opioid agonist/opioid antagonist/acetaminophen combinations
JP2001526228A (ja) 1997-12-22 2001-12-18 ユーロ−セルティーク，エス．エイ． オピオイド作動薬／拮抗薬の併用
CN1525851A (zh) 2001-05-11 2004-09-01 ������ҩ�����޹�˾ 抗滥用阿片样物质控释剂型
EP1492505B1 (en) 2002-04-05 2015-06-03 Euro-Celtique S.A. Pharmaceutical preparation containing oxycodone and naloxone
US20040115263A1 (en) * 2002-08-26 2004-06-17 Robertson David W. Use of bupropion for treating restless legs syndrome
NZ579515A (en) 2003-09-17 2011-09-30 Xenoport Inc Treating or preventing restless legs syndrome using prodrugs of gaba analogs
EP1604667A1 (en) * 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the restless leg syndrome
EP1604666A1 (en) 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
CA2594373A1 (en) * 2005-01-28 2006-08-03 Euro-Celtique S.A. Alcohol resistant dosage forms
EP1695700A1 (en) * 2005-02-28 2006-08-30 Euro-Celtique S.A. Dosage form containing oxycodone and naloxone
EP1702558A1 (en) 2005-02-28 2006-09-20 Euro-Celtique S.A. Method and device for the assessment of bowel function
EP1813276A1 (en) * 2006-01-27 2007-08-01 Euro-Celtique S.A. Tamper resistant dosage forms
RU2478388C2 (ru) * 2008-07-07 2013-04-10 Еуро-Селтик С.А. Фармацевтическая композиция, содержащая опиоидный антагонист, для лечения задержки мочи
WO2010036977A2 (en) * 2008-09-25 2010-04-01 New England Medical Center Hospitals, Inc. Combination therapies with topiramate for seizures, restless legs syndrome, and other neurological conditions
MY152279A (en) 2009-03-10 2014-09-15 Euro Celtique Sa Immediate release pharmaceutical compositions comprising oxycodone and naloxone
US8690933B2 (en) * 2009-08-31 2014-04-08 Brigham Young University System and method for treating symptoms of restless legs syndrome
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
US10071089B2 (en) 2013-07-23 2018-09-11 Euro-Celtique S.A. Combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002539088A (ja) * 1999-02-17 2002-11-19 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド 本態性振せんを処置するのに有用な抗痙攣性誘導体
WO2000061138A1 (en) * 1999-04-08 2000-10-19 Ortho-Mcneil Pharmaceutical, Inc. Anticonvulsant derivatives useful in treating chronic neurodegenerative disorders
PL213323B1 (pl) * 1999-08-20 2013-02-28 Ortho Mcneil Pharm Inc Kompozycja farmaceutyczna i jej zastosowanie
SE0000601D0 (sv) * 2000-02-24 2000-02-24 Jan Hedner Sätt att behandla och diagnostisera andningsstörningar i sömnen och medel för att utföra sättet

Also Published As

Publication number Publication date
EP1429787A1 (en) 2004-06-23
AU2002336765B2 (en) 2007-12-20
JP2005512965A (ja) 2005-05-12
US20030092759A1 (en) 2003-05-15
CA2461539A1 (en) 2003-04-03
WO2003026676A1 (en) 2003-04-03
NZ531871A (en) 2006-09-29

Similar Documents

Publication Publication Date Title
AU2002336765B2 (en) Anticonvulsant derivatives useful for the treatment of restless limb syndrome and periodic limb movement disorder
AU2002336765A1 (en) Anticonvulsant derivatives useful for the treatment of restless limb syndrome and periodic limb movement disorder
US6627653B2 (en) Anticonvulsant derivatives useful for the treatment of depression
US20060122127A1 (en) Methods for reducing the side effects associated with mirtzapine treatment
EP1809286A2 (en) Method for treatment of movement disorders
PT1691811E (pt) Combinação de um sedativo e de um modulador de neurotransmissores e métodos para melhorar a qualidade do sono e tratamento da depressão
EA002554B1 (ru) Применение кабэрголина при лечении синдрома усталых ног
WO2022261263A1 (en) Methods of treating neuropsychiatric disorders
US20100168053A1 (en) Oral delivery system for methylcobalamin to treat disorders
EP4322930A1 (en) Combination of a norepinephrine reuptake inhibitor and a cannabinoid for use in treating sleep apnea
AU2020335372B2 (en) Treatment of menstrual cycle-induced symptoms
Avidan Parasomnias and movement disorders of sleep
WO2010036977A2 (en) Combination therapies with topiramate for seizures, restless legs syndrome, and other neurological conditions
JP2007523052A (ja) 鬱病の処置のための蘇生薬モダフィニルおよび抗鬱薬の組み合わせ
CA3186900A1 (en) Compositions and methods for treating psychiatric disorders or symptoms thereof
US20140148465A1 (en) Compositions and Methods to Improve Treatment of Medical Conditions Using D-Cycloserine
CA2429801A1 (en) Behavior chemotherapy
JP2005508373A (ja) 抗痙攣剤誘導体およびカリウムを用いる共同療法を含んでなる感覚異常の処置および予防
EP2891491A1 (en) Use of (r)-phenylpiracetam for the treatment of sleep disorders
JP7185260B2 (ja) 悪夢障害の治療用医薬組成物
Krasuski Dr. Jack’s MedQuik Guide
HK40075517A (en) Treatment of menstrual cycle-induced symptoms
KR20210135834A (ko) 헤스페리딘을 유효성분으로 함유하는 외상 후 스트레스장애 예방 또는 치료용 조성물
JPWO2014163152A1 (ja) ノンレム睡眠促進剤、深睡眠促進剤および自然睡眠誘発剤

Legal Events

Date Code Title Description
FA Abandonment or withdrawal